A second group, however, does not have TP53 and RB1 but instead possesses frequent mutations in KRAS, STK11, NOTCH1–4, and KEAP1, which are more frequently seen in non-small cell lung cancer (NSCLC) [4]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.